CM
CoFlo Medical, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$500Ksold at filing
Total offering$6M$5.5M still open
Investors in the raise1count reported to the SEC
FiledNov 28, 2025first sale Nov 5, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew GoldmanDirector
Kripa VaranasiDirector
Simon RuferExecutive Officer, Director
Vishnu JayaprakashExecutive Officer
Executive officers, directors and promoters as listed on the Form D.